Recently, the Hunan Provincial Drug Administration, the Human Health Commission, and the Hunan Bureau of Traditional Chinese Medicine jointly issued a “Notice on the Launching of a System for Patient-driven Declaration of Adverse Drug Reactions and the Evaluation of the Efficacy of Hospital-made Drugs.” The Notice stated that beginning on May 1, 2022, hospitals and other medical institutions must download a special QR code for hospital-made drugs through that system and print it in in an obvious position on the instructions, labels, or internal and external packaging of the drugs. Patients who use hospital-made drugs can then scan the QR code with WeChat and log in with their real names to the system to report possible adverse drug reactions and efficacy of the medical drugs used.
湖南三部门联合发文推进医疗机构制剂不良反应与疗效评价工作
来源：新浪财经 2022.03.10
近日，湖南省药监局与省卫健委、省中医药局联合发布《关于启用湖南省患者自主申报医疗机构制剂不良反应与疗效评价系统的通告》。《通知》要求，自2022年5月1日起，各医疗机构应通过“湖南省药品注册信息监管系统”下载制剂二维码，并印刷在制剂说明书、标签或内外包装的显著位置上。患者在使用医疗机构制剂过程中，通过手机微信扫描制剂二维码，实名登陆“湖南省患者自主申报医疗机构制剂不良反应与疗效评价系统”，报告所用制剂的不良反应与疗效。
Leave a Reply